[1]
“Formulation And Assessment Of Transdermal Patches Containing Sustained-Release Haloperidol For The Treatment Of Antipsychotic Illness”, Int. J. Environ. Sci., pp. 1646–1651, Jun. 2025, doi: 10.64252/cmyqhg98.